GBI Research’s latest report, “Substance Abuse Deterrents and Treatments – An Assessment of the Technological, Competitive and R&D Landscape”, discusses global trends in the substance abuse deterrents and addiction treatments market including the impact substance abuse is having on local economies, healthcare systems and society as a whole. This new report provides analyses of current unmet medical needs as well as an in-depth review and assessment of technologies being employed by pharmaceutical manufacturers to reduce the risk of prescription drug misuse and abuse. A series of detailed case studies showcase novel abuse deterrent formulations (ADFs) that have been recently adopted by manufacturers of commonly abused prescription drugs. Although these technologies are relatively nascent, we expect the ADF field to grow rapidly in the coming years driven by strong demand and local government support within many key markets.
Information leveraged from our robust industry-leading database shows a diverse range of drug therapies currently in development for the treatment of substance abuse and addiction, with various novel approaches under investigation. Our new study provides multilevel analysis of both the R&D and marketed product landscape including data and analyses by addiction type, molecule, stage of development, route of administration, company, geographical presence and many other insightful and pertinent analytics. Additionally, the report includes our predictions on the future treatment landscape
Browse Detail Report With TOC @
GBI Research conducted extensive research efforts in order to provide a comprehensive view of the technological, competitive and R&D landscape of the substance abuse deterrents and treatments market. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising commercial areas in the market and exploit key business opportunities.
– How does substance abuse impact individuals, society, the economy and healthcare systems?
– What are the most pertinent commercial trends in the substance abuse deterrents and treatments market?
– What are the most pressing medical needs yet to be addressed regarding substance abuse and addiction?
– What are the most recent advances in abuse deterrent formulation technology?
Marketed products for the treatment of substance abuse and addiction
– What are the products with the highest degree of commercialization?
– What are the indications with the highest volume of marketed products?
– What are the main segments of interest for companies operating in the substance abuse treatments market?
– Who are the leading companies, with the highest volume of products in the market and with the widest geographical presence?
– What are the most prevalent routes of administration of products in the market?
Pipeline therapies for the treatment of substance abuse and addiction
– What role are universities and research institutions playing in the development of novel therapies?
– What indications have the largest number of therapies in development?
– Which companies have the largest portfolios of therapies in development?
– Which therapies are expected to treat multiple indications?
– In which stage of development are most of the pipeline therapies currently concentrated?
– Which types of molecules and routes of administration currently dominate the substance abuse therapies pipeline?
– How will the product and competitive landscape be redefined by the expected launch of novel therapies in the coming years?
Viral Conjunctivitis – Pipeline Review, H1 2016:
Pulmonary Embolism – Pipeline Review, H1 2016:
Key Reasons to Purchase
This report will allow you to –
– Gain insightful analyses and understanding of market dynamics: This report comprehensively describes and assesses the most pertinent commercial, technological, and innovative aspects of the substance abuse deterrents and treatments market.
– Assess marketed and pipeline products for treating substance abuse and addiction: Our new study provides multilevel analyses of the key products currently available for treating various substance abuse addictions as well as promising candidates currently in development.
– Understand current unmet medical needs: This report provides insights regarding the impact substance abuse can have on individuals and society as whole as well as an in-depth gap analysis that helps to identify to the most pressing medical needs yet to be addressed.
– Assess advances in drug deterrent technology, their advantages and their limitations: This report assesses current and novel formulation strategies being implemented by drug manufacturers to reduce the risk of prescription misuse and abuse. Analyses include key advantages, limitations as well as arguments for and against their adoption.
– Assess global trends prevailing in the field of substance abuse deterrents and treatments: This report describes trends at a global level regarding drug use prevalence, regulations and guidelines, as well as the different approaches being taken in different countries to tackle this global issue.
Request A Sample copy of This Report @ http://www.hexareports.com/sample/112646
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Company Name: Hexa Reports
Contact Person: Ryan Shaw
Address:Felton Office Plaza, 6265 Highway 9
Country: United States